Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Office Actions › Mclaughlin Gormley King Company › 16852870
Last updated: October 04, 2026
Application No. 16/852,870

MIXTURES OF SABADILLA ALKALOIDS AND PYRETHROIDS AND USES THEREOF

Final Rejection
Filed
Apr 20, 2020
Priority
Jul 01, 2016 — provisional 62/357,890 +1 more
Examiner
HAGOPIAN, CASEY SHEA
Art Unit
1617
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Mclaughlin Gormley King Company
OA Round
9 (Final)
54%
Grant Probability
Moderate
10-11
OA Rounds
0m
Est. Remaining
88%
With Interview

This examiner grants 54% of cases after interview

— +33.3% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.
Based on 570 resolved cases, 2023–2026

Examiner Intelligence

HAGOPIAN, CASEY SHEA View full profile →
Grants 54% of resolved cases
54%
Career Allowance Rate
310 granted / 570 resolved
-5.6% vs TC avg
Strong +33% interview lift
Without
With
+33.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
42 currently pending
Career history
617
Total Applications
across all art units

Statute-Specific Performance

§101
2.1%
-37.9% vs TC avg
§103
42.4%
+2.4% vs TC avg
§102
12.1%
-27.9% vs TC avg
§112
27.8%
-12.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 570 resolved cases

Prosecution Timeline

Show 15 earlier events
May 16, 2025
Response after Non-Final Action
Jun 03, 2025
Final Rejection mailed
Dec 03, 2025
Request for Continued Examination
Dec 08, 2025
Response after Non-Final Action
May 06, 2026
Non-Final Rejection mailed
May 29, 2026
Response after Non-Final Action
May 29, 2026
Response Filed
Aug 19, 2026
Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/996,399
Patent 12708698
Formulation comprising a phosphocalcic cement and a physical and/or covalent hydrogel of polysaccharides, printable and having ductile mechanical properties for bone regeneration/bone repair
3y 10m to grant Granted Aug 18, 2026
17/769,042
Patent 12691079
A BIODISSOLVABLE FILM FOR LOCALIZED AND EFFICIENT TREATMENT OF VULVODYNIA
4y 3m to grant Granted Jul 28, 2026
17/930,469
Patent 12673139
3D PRINTED UV CROSSLINKING MASKS
3y 10m to grant Granted Jul 07, 2026
18/058,909
Patent 12661430
PARTICLE SUITABLE FOR THE MANUFACTURE OF AN IMPLANTABLE SOFT TISSUE ENGINEERING MATERIAL
3y 6m to grant Granted Jun 23, 2026
18/350,304
Patent 12653785
COMPOSITIONS AND METHODS FOR ADMINISTERING A YAP1/WWRT1 INHIBITING COMPOSITION AND A GLS1 INHIBITING COMPOSITION
2y 11m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

10-11
Expected OA Rounds
54%
Grant Probability
88%
With Interview (+33.3%)
3y 4m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 570 resolved cases by this examiner. Grant probability derived from career allowance rate.

Ready to respond to this office action?

IP Author drafts your complete OA response — amendments, arguments, and claim strategy — in minutes, not days.

Start Drafting Your Response →

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month